Neogen Raises FY2026 Sales Guidance from $820M-$840M to $845M-$855M vs $823.300M Est

Benzinga · 3d ago

Fiscal Year 2026 Outlook

The Company is raising its full-year outlook for fiscal year 2026. Revenue is anticipated to be in the range of $845 million to $855 million and Adjusted EBITDA2 is expected to be approximately $175 million. Capital expenditures continue to be expected to total approximately $50 million.